Funding for this research was provided by:
Deutsche Krebshilfe (111454)
FP7 People: Marie-Curie Actions (MC-IIF-623984)
European Research Council (2009-AdG 232997)
Health and Medical Research Fund (PI13/00061, PI13/01162)
Cancer Research UK (C570/A16491, 14136, C8221/A19170)
Medical Research Council (1000143, MR/M012190)
Text and Data Mining valid from 2018-10-22
Received: 7 March 2018
Accepted: 2 October 2018
First Online: 22 October 2018
Ethics approval and consent to participate
: This project was approved by the International Agency for Research on Cancer (IARC) Ethics Committee (Project No. 12–42) and the University of Heidelberg Ethics Commission (Project No. S311/2014). The EPIC study protocol was approved by the ethical committees of IARC and the participating centers. All participants provided informed consent.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.